Inogen Inc (INGN)
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Sector: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Industry: Medical - Devices
Inogen, Inc.
Trials need funding. See this company's dilution risk and cash position.
- Not applicableCompleted
Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study.
Inogen One® G4
COVID-19
NCT05212831Enrollment21StartJun 2022Primary CompletionMar 2023CompletionMar 2023 - Not applicableCompleted
Portable Oxygen Concentrator in Non-hospitalized Patients With Chronic Heart Failure
Inogen Rove 6 Portable Oxygen Concentrator
Heart Failure
NCT05719363Enrollment20StartOct 2023Primary CompletionNov 2023CompletionNov 2023 - Not applicableCompleted
Evaluation of POC Pulse-dose Demand Oxygen Delivery for Nocturnal Hypoxemia
InogenOne Rove 6 Portable Oxygen Concentrator
Nocturnal Hypoxemia
NCT06000332Enrollment20StartOct 2023Primary CompletionDec 2023CompletionDec 2023 - Not applicableCompleted
Acute Effects of Supplemental Oxygen on Memory Testing in Healthy Adult Volunteers
Cross Over Assignment Supplemental Oxygen and Supplemental Air
Cognition
NCT06555484Enrollment40StartMay 2024Primary CompletionOct 2024CompletionOct 2024 - Not applicableNot yet recruiting
Simeox 200 US Study
Intermittent intrapulmonary deflation
Bronchiectasis, Mucus; Plug
NCT07443124Enrollment35StartFeb 2026est.Primary CompletionMay 2026est.CompletionJun 2026est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Not applicable | Completed | Inogen One® G4 | NCT05212831 |
| Not applicable | Completed | Inogen Rove 6 Portable Oxygen Concentrator | NCT05719363 |
| Not applicable | Completed | InogenOne Rove 6 Portable Oxygen Concentrator | NCT06000332 |
| Not applicable | Completed | Cross Over Assignment Supplemental Oxygen and Supplemental Air | NCT06555484 |
| Not applicable | Not yet recruiting | Intermittent intrapulmonary deflation | NCT07443124 |